Patrice Garnier

Direktor/Vorstandsmitglied bei Meletios Therapeutics SAS

Health Technology

Aktive Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Catherine Martre	F	-	Meletios Therapeutics SAS Meletios Therapeutics SAS BiotechnologyHealth Technology Meletios Therapeutics SAS is a French biotech company founded in 2020 by a team of high level scientists and experienced biotech managers. The company is based in Lyon, France. The company's aim is to fulfill the urgent and large unmet medical need for broad spectrum treatments against current and emerging viral infections. One of their first drug candidates has confirmed its broad-spectrum potential. Catherine Martre has been the CEO of the company since 2021.	3 Jahre
Alexandre Mouradian	M	54	Meletios Therapeutics SAS Meletios Therapeutics SAS BiotechnologyHealth Technology Meletios Therapeutics SAS is a French biotech company founded in 2020 by a team of high level scientists and experienced biotech managers. The company is based in Lyon, France. The company's aim is to fulfill the urgent and large unmet medical need for broad spectrum treatments against current and emerging viral infections. One of their first drug candidates has confirmed its broad-spectrum potential. Catherine Martre has been the CEO of the company since 2021.	-
Rodolphe Besserve	M	51	Meletios Therapeutics SAS Meletios Therapeutics SAS BiotechnologyHealth Technology Meletios Therapeutics SAS is a French biotech company founded in 2020 by a team of high level scientists and experienced biotech managers. The company is based in Lyon, France. The company's aim is to fulfill the urgent and large unmet medical need for broad spectrum treatments against current and emerging viral infections. One of their first drug candidates has confirmed its broad-spectrum potential. Catherine Martre has been the CEO of the company since 2021.	-
Gérard Le Fur	M	73	Meletios Therapeutics SAS Meletios Therapeutics SAS BiotechnologyHealth Technology Meletios Therapeutics SAS is a French biotech company founded in 2020 by a team of high level scientists and experienced biotech managers. The company is based in Lyon, France. The company's aim is to fulfill the urgent and large unmet medical need for broad spectrum treatments against current and emerging viral infections. One of their first drug candidates has confirmed its broad-spectrum potential. Catherine Martre has been the CEO of the company since 2021.	-